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Abstract
A major theme in constraint-based modeling is unifying experimental data, such as biochemical information
about the reactions that can occur in a system or the composition and localization of enzyme complexes, with high-
throughput data including expression data, metabolomics, or DNA sequencing. The desired result is to increase
predictive capability and improve our understanding of metabolism. The approach typically employed when only
gene (or protein) intensities are available is the creation of tissue-specific models, which reduces the available reac-
tions in an organism model, and does not provide an objective function for the estimation of fluxes. We develop a
method, flux assignment with LAD (least absolute deviation) convex objectives and normalization (FALCON), that
employs metabolic network reconstructions along with expression data to estimate fluxes. In order to use such a
method, accurate measures of enzyme complex abundance are needed, so we first present an algorithm that addresses
quantification of complex abundance. Our extensions to prior techniques include the capability to work with large
models and significantly improved run-time performance even for smaller models, an improved analysis of enzyme
complex formation, the ability to handle large enzyme complex rules that may incorporate multiple isoforms, and
either maintained or significantly improved correlation with experimentally measured fluxes. FALCON has been
implemented in MATLAB and ATS, and can be downloaded from: https://github.com/bbarker/FALCON . ATS
is not required to compile the software, as intermediate C source code is available. FALCON requires use of the
COBRA Toolbox, also implemented in MATLAB.
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1 Introduction
FBA (flux balance analysis) is the oldest, simplest, and perhaps most widely used linear constraint-based metabolic
modeling approach [1, 2]. FBA has become extremely popular, in part, due to its simplicity in calculating reasonably
accurate microbial fluxes or growth rates (e.g. Schuetz et al. 3, Fong and Palsson 4); for many microbes, a simple
synthetic environment where all chemical species are known suffices to allow proliferation, giving fairly complete
constraints on model inputs. Additionally, it has been found that their biological objectives can be largely expressed
as linear objectives of fluxes, such as maximization of biomass [3]. Neither of these assumptions necessarily hold for
mammalian cells growing in vitro or in vivo, and in particular the environment is far more complex for mammalian cell
cultures, which have to undergo gradual metabolic adaptation via titration to grow on synthetic media [5]. Recently,
there have been many efforts to incorporate both absolute and differential expression data into metabolic models
[6]. The minimization of metabolic adjustment (MoMA; Segre` et al. 7) algorithm is the simplest metabolic flux
fitting algorithm, and it can be extended in order to allow the use of absolute expression data for the estimation of
flux [8], which is the approach taken in this study. A different approach for using expression in COBRA, also very
simple, is E-flux, which simply uses some function of expression (chosen at the researcher’s discretion; typically a
constant multiplier of expression) as flux constraints [9]. Despite this surprising simplicity, the method has found many
successful applications, but the user-chosen parameter and use of expression as hard constraints is, in our opinion, a
detraction, and others have had better results taking an approach similar to Lee et al. 8 [10].
The MoMA method, framed as a constrained least-squares optimization problem, is typically employed to calculate
the flux vector of an in silico organism after a mutation by minimizing the distance between the wild-type flux and
the mutant flux. The biological intuition is that the organism has not had time to adapt to the restricted metabolic
capacity and will maintain a similar flux to the wild-type (WT) except where the perturbations due to the mutation
dictate necessary alterations in fluxes [11]. Suppose a is the WT flux vector obtained by an optimization procedure
such as FBA, empirical measurements, or a combination of these. For an undetermined flux vector v in a model with
N reactions the MoMA objective can be expressed as
minimize
N∑
i=1
(vi − ai)2 (1)
subject to the stoichiometric constraints Sv = 0 where v = (v1, . . . , vN)T and S is the stoichiometric matrix (rows
correspond to metabolites, columns to reactions, and entries to stoichiometric coefficients). Constant bounds on fluxes
are often present, such as substrate uptake limits, or experimental Vmax estimates, so we write these as the constraints
vlb  v  vub. The objective may be equivalently expressed in the canonical quadratic programming (QP) vector form
as min. 12 v
T v − aT v. This assumes that each ai is measured, but it is also possible and sometimes even more useful to
employ this objective when only a subset of the ai are measured (if ai is not measured for some i, then we omit (vi−ai)2
from the objective). In metabolomics, for instance, it is always the case in experiments with labeled isotope tracers
that only a relatively small subset of all fluxes are able to be estimated with metabolic flux analysis (MFA; Shestov
et al. 1). Combining MoMA with MFA provides a technique to potentially estimate other fluxes in the network.
A variant of MoMA exists that minimizes the absolute value of the difference between ai and vi for all known ai.
To our knowledge, the following linear program is the simplest version of linear MoMA, which assumes the existence
of a constant flux vector a:
minimize
N∑
i=1
di
subject to Sv = 0
vlb  v  vub
∀i : −di ≤ vi − ai ≤ di
di ≥ 0
(2)
The di are just the distances from a priori fluxes to their corresponding fitted fluxes. Linear MoMA has the
advantage that it is not biased towards penalizing large magnitude fluxes or under-penalizing fluxes that are less
than one [11, 12]. Additionally, linear programs are often amenable to more alterations that maintain convexity than
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a quadratic program and tend to have fewer variables take on small values, and it is much easier to interpret the
importance of a zero than a small value [12].
We wish to apply MoMA to expression data rather than flux data, but there are two primary problems that must be
tackled. First, we must quantify enzyme complex abundance as accurately as possible given the gene expression data.
Although there is not a one-to-one correspondence between reactions and enzyme complexes, the correspondence is
much closer than that between individual genes and metabolic reactions. In the first part of this work, we employ an
algorithm that can account for enzyme complex formation and thus quantify enzyme complex abundance. Second,
we must fit real-valued variables (fluxes) to non-negative data (expression), which is challenging to do efficiently. To
accomplish this, we build on the original MoMA objective, which must be altered in several ways (also discussed in
Lee et al. 8, which lays the groundwork for the current method). We develop automatic scaling of expression values
so that they are comparable to flux units obtained in the optimization routine. This can be an advantage over the prior
method as it no longer requires the manual choice of a flux and complex abundance pair with a ratio that is assumed
to be representative of every such pair in the system. Related to this, we also implement the sharing of enzyme
complex abundance between the reactions that the complex catalyzes, rather than assuming there is no competition
between reactions catalyzed by the same complex. Reaction direction assignment enables comparison of fluxes and
expression by changing fluxes to non-negative values. We show that batch assignment, rather than serial assignment
[8] of reaction direction can greatly improve time efficiency while maintaining or slightly improving correlations with
experimental fluxes. In addition to several of the methods described so far, we also included in our comparison two
methods for tissue-specific modeling. In GIMME, the authors remove reactions whose associated gene expression
is below some threshold, then add reactions that preclude some user-defined required metabolic functionalities in an
FBA objective back into the model, and finally use FBA again to obtain fluxes [13]. The other tissue-specific method
we compared with is iMAT, which employs a mixed integer linear programming (MILP) problem to maximize the
number of reactions whose activity corresponds to their expression state (again using thresholds, but this time, there
are low, medium, and highly expressed genes, and only the lowly and highly expressed genes are included in the
objective) all while subject to typical constraints found in FBA [14].
Finally, we employ several sensitivity analyses and performance benchmarks so that users of the FALCON method
and related methods may have a better understanding of what to expect in practice.
2 Methods
Most genome-scale models have attached Boolean (sans negation) gene rules to aid in determining whether or not a
gene deletion will completely disable a reaction. These are typically called GPR (gene-protein-reaction) rules and are
a requirement for FALCON; their validity, like the stoichiometric matrix, is important for generating accurate predic-
tions. Also important are the assumptions and limitations for the process of mapping expression data to complexes so
that a scaled enzyme complex abundance (hereafter referred to as complex abundance) can be estimated. We address
these in the next section and have attached a flow chart to illustrate the overall process of mapping expression of indi-
vidual genes to enzyme complexes within the greater context of flux estimation (Figure 1). We employ an algorithm
for this step—finding the minimum disjunction—for estimating complex abundance as efficiently and as accurately as
possible given the assumptions (Section 8).
Consideration of constraint availability, such as assumed reaction directions and nutrient availability, is crucial
in this type of analysis. In order to work with two sets of constraints with significantly different sizes in yeast, we
wrote the MATLAB function removeEnzymeIrrevs to find all enzymatic reactions in a model that are annotated as
reversible but are constrained to operate in one direction only. This is not something a researcher would normally want
to do since constraints should generally act to improve modeling predictions, but we are interested to see how their
removal influences model predictions and solution robustness.
The function useYN5irrevs copies the irreversible annotations found in Yeast 5.21 [8] to a newer yeast model,
but could in principle be used for any two models; by default, this script is coded to first call removeEnzymeIrrevson
both models before copying irreversible annotations. Application of these scripts removes 853 constraints in Yeast 5.21
and 1,723 constraints in Yeast 7. Despite the significant relaxation in constraints, since nutrient uptake constraints are
unaffected, FBA only predicts a 1.28% increase in growth rate in the minimally constrained Yeast 7 model. However,
in FALCON, we are no longer optimizing a sink reaction like biomass, and this relaxation in internal constraints proves
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to be more important. Constraint sets for Human Recon 2 are described in Figure 8.
2.1 Estimating enzyme complex abundance
Given the diversity and availability of genome-scale expression datasets, either as microarray or more recently RNA-
Seq, it could be useful to gauge the number of enzyme complexes present in a cell. A recent study found that only
11% of annotated Drosophila protein complexes have subunits that are co-expressed [15], so it cannot be assumed that
any given protein subunit level represents the actual complex abundance. We formalize a model for enzyme complex
formation based on GPR rules that are frequently available in genome-scale annotations.
The original expression to complex abundance mapping procedure [8] performed a direct evaluation of GPR rule
expression values—replacing gene names with their expression values, ANDs with minimums, and ORs with sums,
without altering the Boolean expression of the GPR rule in any way. Below we illustrate a problem that can occur with
this mapping where some genes’ expression levels may be counted more than once.
The ri are different reaction rules and the ei are the corresponding estimated complex abundance levels. Lower
case letters are shorthand for the expression level of the corresponding gene ID in uppercase; for example, a = E (A),
where E (A) is the expression of gene A.
r1 := [A and B] or [A and C] → e1 = min(a, b) + min(a, c)
r2 := [A and (B or C)] → e2 = min(a, b + c) (3)
Supposing A is the minimum, then if we just evaluate r1 directly (a rule in disjunctive normal form, or DNF), A will
be counted twice. Rules with sub-expressions in DNF are frequently encountered in practice, but directly evaluating
them can lead to erroneous quantification.
Another possibility is partitioning expression among multiple occurrences of a gene in a rule. For instance, in r1
above, we could evaluate it as e1 = min( a2 , b) + min( a2 , c) to account for the repeated use of a. However, other potential
issues aside, we can see that this can cause problems rather quickly. For instance, suppose b = a and c = 0; then
min(a,b + c) = b = a appears to be correct, not min( a2 , b) + min( a2 , c) = a2 + 0. From this example, we can see that
conversion to conjunctive normal form (CNF; Russell and Norvig 16), as in r2 appears to be a promising prerequisite
for evaluation.
2.2 The min-disjunction algorithm estimates enzyme complex abundance
In Section 8, we show that converting a rule to CNF is a sound method to aid in the estimation of enzyme complex
abundance. The minimum disjunction algorithm is essentially just the standard CNF conversion algorithm [16], with
the implementation caveat that a gene that is in disjunction with itself should be reduced to a literal. We’ve found
that this makes the CNF conversion algorithm tractable for all rules and prevents double counting of gene expression.
Conversion to CNF and selection of the minimum disjunction also removes redundant genes from the complex (e.g.
holoenzymes; see Assumption 8). Biologically, selecting the minimum disjunction effectively finds the rate-limiting
component of enzyme-complex formation. After conversion to CNF, the minimum disjunction algorithm substitutes
gene-expression values as described in Lee et al. 8 and evaluates the resulting arithmetic expression. Another new
feature of our approach is the handling of missing gene data. If expression is not measured for a gene in a GPR rule,
the rule is modified so that the missing gene is no longer part of the Boolean expression. For instance, if data is not
measured for gene B in [A and (B or C)] then the rule would become [A and C]. This prevents penalization of the
rule’s expression value in the case that the missing gene was part of a conjunction, and it also assumes there was no
additional expression from the missing gene if it is in a disjunction.
Although conversion to CNF may be intractable for some expressions [16], we tested our implementation of the
algorithm on three of the most well-curated models which contain some of the most complex GPR rules available.
These models are for E. coli [17], yeast [18], and human [19]. In all cases, the rules were converted to CNF in less
than half a second, which is far less than the typical flux fitting running time from Algorithm 3.1.
Using the minimum disjunction method results in several differences from direct substitution and evaluation in
yeast GPR rules. When data completely covers the genes in the model (e.g. Lee et al. 8), complex abundance tends
to have few differences in yeast regardless of the evaluation method (25 rules; 1.08% of all rules for Yeast 7). This
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Genes:
expression (µ, σ) Reactions: GPR Rule
Parse Rule
Find minimum disjunction
Reactions (enzyme complexes):
abundance (µ, σ)
S matrixReactions:flux bounds (vlb, vub)
Flux fitting (FALCON)
Reactions:
fluxes (v : µ, σ)
Figure 1: Flowchart illustrating the two algorithms used in this paper. The process of estimating enzyme complex
abundance is displayed in detail, whereas the flux-fitting algorithm (FALCON) is illustrated as a single step for sim-
plicity. First, for each gene in the model with available expression data, the mean and (if available) standard deviation
or some other measure of uncertainty are read in. Gene rules (also called GPR rules) are also read in for each enzy-
matic reaction. The reaction rules are parsed and the minimum disjunction algorithm is applied, making use of the
gene’s mean expression. Next, the estimated and unitless enzyme complex abundance and variance are output for
each enzymatic reaction. Finally, flux fitting with FALCON (Algorithm 3.1) can be applied, and requires the model’s
stoichiometry and flux bounds. The final output has the option of being a deterministically estimated flux, or a mean
and standard deviation of fluxes if alternative optima are explored.
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number goes up significantly in Human Recon 2 [19] due to more complex GPR rules (935 rules; 22% of all rules). For
the human model, we could not find any data set that covered every gene, so instead random expression data roughly
matching a power law was used to generate this statistic. If we use proteomics data for yeast and human models, the
algorithmic variation in how missing gene data is handled causes some additional increase in differences [20, 21]. For
proteomics, in the Yeast 7 model 205 rules (8.87% of all rules) differed, and in Human Recon 2, 1002 rules (23.57%
of all rules) differed. We can see that for yeast, the changes in flux attributed to enzyme abundance evaluation can be
relatively small for data with 100% gene coverage, but can be significant in Human (Figure 5).
3 The FALCON algorithm
Prior work that served as an inspiration for this method used Flux Variability Analysis (FVA) to determine reaction
direction [8]. Briefly, this involves two FBA simulations per reaction catalyzed by an enzyme, and as the algorithm
is iterative, this global procedure may be run several times before converging to a flux vector. We removed FVA to
mitigate some of the cost, and instead assign flux direction in batch; while it is possible that the objective value may
decrease in subsequent iterations of the algorithm, this is not an issue since the objective function is changed at each
iteration to include more irreversible fluxes. The objective value of a function with more fluxes should supersede the
importance of one with fewer fluxes, as the functions are not the same and thus not directly comparable, and we wish
to include as many data points in the fitting as possible.
One major advance in our method is the consideration of enzyme complexes sharing multiple reactions, which we
call reaction groups. This is done by partitioning an enzyme complex’s abundance across its reactions by including
all reactions associated to the complex in the same constraint. Both minimally and highly constrained models (Sec-
tion 4.2) show some fluxes with significant differences depending on the use of group information, particularly in the
minimally constrained model (Figure 2). We now discuss the algorithm in detail, including several other important
features, including automatic scaling of expression.
To make working with irreversible fluxes simpler, we convert the model to an irreversible model, where each
reversible flux v j in the original model is split into a forward and a backward reaction that take strictly positive values:
v j, f and v j,b. We also account for enzyme complexes catalyzing multiple reactions by including all reactions with
identical GPR rules in the same residual constraint; indexed sets of reactions are denoted Ri and their corresponding
estimated enzyme abundance is ei. Figure 2 shows the difference in Algorithm 3.1 when we do not use reaction group
information. The standard deviation of enzyme abundance, σi, is an optional weighting of uncertainty in biological or
technical replicates.
We employ a normalization variable n in the problem’s objective and flux-fitting constraints to find the most
agreeable scaling of expression data. The linear fractional program shown below can be converted to a linear program
by the Charnes-Cooper transformation [12]. To avoid the need for fixing any specific flux, which may introduce bias,
we introduce the bound ∑ j | ∃i s.t. j∈Ri
∣∣∣v j
∣∣∣ ≥ VΣlb. This guarantees that the optimization problem will yield a non-zero
flux vector. As an example of how this can be beneficial, this means we do not need to measure any fluxes or assume
a flux is fixed to achieve good results; though this does not downplay the value of obtaining experimentally-based
constraints on flux when available (Figure 6).
The actual value of VΣlb is not very important due to the scaling introduced by n, and we include a conservatively
small value that should work with any reasonable model. However, for numeric reasons, it may be best if a user
chooses to specify a value appropriate for the model. Similarly, if any fluxes are known or assumed to be non-zero,
this constraint becomes unnecessary. To keep track of how many reactions are irreversible in the current and prior
iteration, we use the variables rxnsirrev and rxnsirrev,prior . The algorithm terminates when no reactions are constrained
to be exclusively forward or backward after an iteration.
Algorithm 3.1 and the method in Lee et al. 8 are both non-deterministic. In the first case, Algorithm 3.1 solves
an LP during each iteration, and subsequent iterations depend on the LP solution, so that alternative optima may
affect the outcome. In the latter case, alternative optima of individual LPs is not an issue, but the order in which
reactions assigned to be irreversible can lead to alternative solutions. However, we found that the variation due to this
stochasticity is typically relatively minor, particularly in cases where the model is more heavily constrained (Figs. 5
and 6).
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Figure 2: Comparison of setting FALCON to use no reaction group information (x-axis) versus with group information
(y-axis; default FALCON setting) for both the highly constrained Yeast 7 model (a) and the minimally constrained
Yeast 7 model (b). Error bars with length equal to one standard deviation are shown for both approaches as a result of
alternative solutions in FALCON.
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Algorithm 3.1. FALCON
INPUT: {Ri : i an index for a unique enzyme complex where
Ri = { j : complex i catalyzes reaction j}}
INPUT: enzyme abundances (mean: ei, standard deviation: σi)
INPUT: model (S matrix, vlb, vub)
umin ← min j {V j,max : V j,max > 0} where V j,max = max
(∣∣∣vlb, j
∣∣∣ ,
∣∣∣vub, j
∣∣∣
)
.
VΣlb ← umin |{ j : ∃i s.t. j ∈ Ri}|
rxnsirrev ← number of reactions ( j) such that either vub, j > 0 or vlb, j < 0, but not both.
for all i do
Scale data to be of similar size for numeric stability:
ei ←
eiVΣlb∑
j
ei
σi ←
σiVΣlb∑
j
ei
end for
while rxnsirrev > rxnsirrev,prior do
rxnsirrev,prior ← rxnsirrev
Call LP Solver (updates v):
minimize
∑
i
di
nσi
s.t.∑
j | ∃i s.t. j∈Ri
∣∣∣v j
∣∣∣ ≥ VΣlb
∀i : −di ≤
∑
j∈Ri (v j, f + v j,b) − nei ≤ di where v j = v j, f − v j,b
di, v j, f , v j,b ≥ 0
n > 0
for all
{
j | v j, f + v j,b > 0, v j, f , v j,b
}
do
Constrain the smaller of v j, f and v j,b to be 0.
rxnsirrev ← rxnsirrev + 1
end for
end while
OUTPUT: v
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Table 1: Performance of FALCON and other CBM methods for predicting yeast exometabolic fluxes in two growth
conditions with highly (HC) and minimally (MC) constrained models (a) and associated timing analysis (b). For Lee
et al. and FALCON methods, the mean time for a single run of the method is listed; all other methods did not have any
stochasticity employed. Values are shown in two significant figures. Method descriptions can be found in Lee et al. 8.
(a) Max. µ Model Experimental Standard FBA Fitted FBA GIMME iMAT Lee et al. FALCON
75 % Yeast 5 MC 1 0.66 0.66 NaN 0.57 0.64 1
75 % Yeast 7 MC 1 0.66 0.66 0.68 0.66 0.66 0.98
75 % Yeast 5 HC 1 0.73 0.78 0.75 0.66 0.98 0.99
Pearson’s r 75 % Yeast 7 HC 1 0.70 0.70 0.80 0.66 0.98 0.99
85 % Yeast 7 MC 1 0.62 0.62 0.65 0.62 0.62 0.97
85 % Yeast 5 HC 1 0.88 0.89 0.9 0.81 0.99 0.99
85 % Yeast 7 HC 1 0.67 0.67 0.87 0.62 0.98 0.98
(b) Max. µ Model Experimental Standard FBA Fitted FBA GIMME iMAT Lee et al. FALCON
75 % Yeast 5 MC 0 0.9 470 0.81 50 110 1.8
75 % Yeast 7 MC 0 1.9 3,100 2.1 12,000 600 5.6
75 % Yeast 5 HC 0 0.12 110 0.18 1.4 15 0.27
Time (s) 75 % Yeast 7 HC 0 0.72 940 1.7 240 670 5.5
85 % Yeast 7 MC 0 2.3 3,100 3.8 14,000 610 4.6
85 % Yeast 5 HC 0 0.12 110 0.18 2.5 15 0.22
85 % Yeast 7 HC 0 0.70 110 2.5 100 530 5.9
4 Results and Discussion
4.1 Performance benchmarks
Using the same yeast exometabolic and expression data employed for benchmarking in the antecedent study [8] that
included an updated version of the Yeast 5 model [22] and the latest yeast model [18], we find that our algorithm has
significant improvements in time efficiency while maintaining correlation with experimental fluxes, and is much faster
than any similarly performing method (Table 1; Figure 6). Timing for the human model also improved in FALCON;
in a model with medium constraints and exometabolic directionality constraints, FALCON completed on average in
3.6 m and the method from Lee et al. 8 in 1.04 h. Furthermore, when we remove many bounds constraining the
direction of enzymatic reactions that aren’t explicitly annotated as being irreversible in prior work [8], we find that our
formulation of the approach seems to be more robust than other methods.
We see that the predictive ability of the algorithm does not appear to be an artifact; when FALCON is run on
permuted expression data, it doesn’t do as well as the actual expression vector (Figure 3). The full-sized flux vectors
estimated from permuted expression as a whole also does not correlate well with the flux vector estimated from the
actual expression data, but we notice that the difference is visibly larger in the minimally constrained model compared
to the highly constrained model (Figure 7). Rigidity in the highly constrained model appears to keep most permutations
from achieving an extremely low Pearson correlation, likely due to forcing fluxes through the same major pathways,
but a rank-based correlation still shows strong differences.
4.2 Sensitivity to expression noise
To understand the sensitivity of flux to expression, we multiply noise from multivariate log-normal distributions with
the expression vector and see the effect on the estimated fluxes. For instance, correlation between two types of
proteomics data yields a Pearson’s r = 0.7 [21], corresponding to an expected σ ≈ 1.4 and expected r ≈ 0.4 for flux
in our most highly constrained human model (Figure 8). We find that enzymatic reaction directionality constraints
influence the sensitivity of the model to expression perturbation (Figure 4). It is important to note that mere presence
of the constraints does not help us determine the correct experimental fluxes when other classes of methods (e.g. FBA;
Table 1) are used. Additionally, it is possible to obtain good predictions even without a heavily constrained model
(Table 1).
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Figure 3: Kernel-smoothed PDFs of correlation between experimental fluxes and fluxes estimated from FALCON
when all gene expression data points are permuted. Arrows mark the correlation when FALCON is run on the unper-
muted expression data. Random correlations tend to be much more positive in the highly constrained model (a) than
in the minimally constrained model (b). 5,000 permutation replicates were performed in all cases.
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With Human Recon 2, additional constraint sets supply some benefit, but even the most extreme constraint set does
not compare to what is available in Yeast 7, which is also inherently constrained by the fact that yeast models will be
smaller than comparable human models (Figure 8). For mammalian models, more sophisticated means of constraint,
such as enzyme crowding constraints [23], or using FALCON in conjunction with tissue specific modeling tools, may
prove highly beneficial.
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Figure 4: Correlation of perturbed enzyme abundance vectors and flux vectors with the associated unperturbed vector
for the Yeast 7 model. The interval median correlation is shown in green. Noise sampled from a multivariate log-
normal distribution with parameters µ = 1 and σ (x-axis) is multiplicatively applied to the enzyme abundance vector,
and the y-axis shows the Pearson correlation between the two vectors (a). Similar plots show correlation between flux
vectors estimated with FALCON using the same perturbed and unperturbed expression vectors (b-c).
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4.3 Flux estimates provides information beyond enzyme complex abundance
It is not an unreasonable hypothesis that fluxes would correlate well with their associated complex abundances. In-
deed, the general principle needed for fitting fluxes to enzyme complex abundances is to assume the values would be
correlated in the absence of other constraints (e.g. branch points that arise from the stoichiometry). More specifically,
it should be the case that flux is proportional to enzyme complex abundance given ample availability of substrate,
and that this proportionality constant does not vary too much between reactions. There are undoubtedly many excep-
tions to this rule, but it seems as though there may be some underlying evolutionary principles for it to work in this
parsimonious fashion, as has been partly verified [24].
Aside from the obvious benefits of constraint-based methods also estimating fluxes for non-enzymatic reactions,
and assigning a direction for reversible enzymatic reactions, we see that in general, our method does not predict a
strong correlation between complex abundance and flux (Figure 9). Recently it has been shown that many fluxes are
not under direct control of their associated enzyme expression level [25], which gives experimental support to the idea
that a network-based approach, such as that presented in this paper, may be useful in understanding how fluxes may
be constrained by expression data. Chubukov et al. 25 also note that enzymes may be overexpressed in some cases,
either for robustness or because of noise in transcriptional regulation. This will not usually be a problem in FALCON,
unless entire pathways are overexpressed, which would be unusual as it would represent a seemingly large energetic
inefficiency.
The present work doesn’t attempt to use empirically obtained kinetic parameters to estimate Vmax, but this approach
does not seem as promising in light of experimental evidence that many reactions in central carbon metabolism tend to
operate well below Vmax [24]. Still, a better understanding of these phenomena may make it possible to improve flux
estimation methods such as the one presented here, or more traditional forms of MFA [1] by incorporating enzyme
complexation and kinetic information.
4.4 Increasing roles for GPR rules and complex abundance estimates
Still, complex abundance may have uses aside from being a first step in FALCON. The method presented here for
complex abundance estimation can be used as a stand-alone method, as long as GPR rules from a metabolic recon-
struction are present. For instance, it may not always be desirable to directly compute a flux. As an example, the
relative abundance of enzyme complexes present in secretions from various biological tissues, such as milk or pan-
creatic secretions, may still be of interest even without any intracellular flux data. Perhaps more importantly, this
approach to estimating relative complex levels can be employed with regulatory models such as PROM [26] or other
regulatory network models that can estimate individual gene expression levels at time t+1 given the state of the model
at a time t.
GPR rules and stoichiometry may be inaccurate or incomplete in any given model. In fact, for the foreseeable
future, this is a given. By using the GPR and not just the stoichiometry to estimate flux, it is possible that future
work could make use of this framework to debug not just stoichiometry as some methods currently do (e.g. Reed
et al. 27) , but also GPR rules. Hope for improved GPR rule annotation may come from many different avenues of
current research. For instance, algorithms exist for reconstructing biological process information from large-scale
datasets, and could be tuned to aid in the annotation of GPR rules [28]. Flexible metabolic reconstruction pipelines
such as GLOBUS may also be extended to incorporate GPR rules into their output, and in so doing, extend this type
of modeling to many non-model organisms [29]. Another limitation that relates to lack of biological information is
that we always assume a one-to-one copy number for each gene in a complex. Once more information on enzyme
complex structure and reaction mechanism becomes available, an extension to the current method could make use of
this information. Even at the current level of structure, we think it is evident that GPR rules should undergo some
form of standardization; Boolean rules without negation may not always capture the author’s intent for more complex
purposes like flux fitting.
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5 Conclusion
We have formalized and improved an existing method for estimating flux from expression data, as well as listing
detailed assumptions in Table 2 that may prove useful in future work. Although we show that expression does not
correlate well with flux, we are still essentially trying to fit fluxes to expression levels. The number of constraints
present in metabolic models (even the minimally constrained models) prevents a good correlation between the two.
However, as with all constraint-based models, constraints are only part of the problem in any largely underdetermined
system. We show that gene expression can prove to be a valuable basis for forming an objective, as opposed to
methods that only use expression to further constrain the model by creating tissue-specific or condition-specific models
[9, 13, 14, 30].
For better curated models, the approach described immediately finds use for understanding metabolism, as well
as being a scaffold to find problems for existing GPR rules, and more broadly the GPR formalism itself. The present
results and avenues for future improvement show that there is much promise for using expression to estimate fluxes,
and that it can already be a useful tool for performing flux estimation and analysis.
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Figure 5: Comparison of fluxes when FALCON is run with enzyme abundance calculated by direct evaluation (x-axis)
and the minimum disjunction algorithm (y-axis); error bars with length equal to one standard deviation are shown for
both approaches as a result of alternative solutions in FALCON. Yeast was evaluated with default (highly) constrained
(a) and minimally constrained (b) models, and no strong difference between direct evaluation or or the minimum
disjunction method is observed in either case. However, for human models with a highly constrained reaction set
(RPMI media, CORE-sign, and enzymatic direction) (c) and default constraints (d), we see there is a large amount of
variation between the two evaluation techniques. In the human cases, two outliers were not shown that correspond to a
single large flux cycle (‘release of B12 by simple diffusion’ and ‘transport of Adenosylcobalamin into the intestine’).
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Figure 6: Shown are flux predictions using a number of methods and four different models (Yeast 5 MC and Yeast 7
MC are minimally constrained Yeast 5 and Yeast 7; Yeast 5 HC and Yeast 7 HC are highly constrained Yeast 5 and
Yeast 7). Error bars are shown for the Lee et al. method and for FALCON, where one side of the error bar corresponds
to a standard deviation. Note that there can be no variation for glucose in the former case since glucose flux is fixed
as part of the method. FALCON performs very well for large fluxes (a-c), and is also the best performer in general
for the next largest flux, glycerol (d). It also has sporadic success for smaller fluxes, but all methods seem to have
trouble with the smallest fluxes (e.g. e). Note that fluxes are drawn in log scale (specifically a flux v is drawn as
sgn (v) log10 (1 + v)). Similar results are obtainable for the 85% maximum growth condition.
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Figure 7: Kernel-smoothed PDFs are drawn for correlations between the entire flux vector estimated by FALCON on
permuted and unpermuted data. Stability and correlation are effected by constraints, as there are differences between
the minimally constrained (b, d) and highly constrained (a, c) Yeast 7 models. 5,000 permutation replicates were
performed in all cases.
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Figure 8: These figures are generated in the same way as those in Figure 4, but for Human Recon 2 instead of Yeast 7,
where (a) again shows how noise applied to an expression vector (x-axis) influences the Pearson correlation between
the perturbed and unperturbed expression vectors (y-axis). We used several different constraint sets based on experi-
mental media and exometabolic flux data in the NCI-60 cell lines [31]. These constraints were applied cumulatively,
and are listed in the order of most constrained (b) to least constrained (f). Included are default Recon 2 constraints
(f), RPMI media constraints (e; function constrainCoReMinMaxSign; 556 constraints), exometabolic fluxes with
a common sign across all cell lines and replicates (d; function constrainCoReMinMaxSign; 567 cumulative con-
straints), enzymatic reaction directionality constraints from a linear MoMA fitting on the exometabolic flux data that
agree across all NCI-60 cell lines (c; constrainImputedInternal; 593 cumulative constraints), and the same again
considering all reactions instead of only enzymatic reactions (b; 618 cumulative constraints).
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Figure 9: Pearson correlation between FALCON flux magnitudes, prerequisite enzyme complex estimates (from
minDisj), and various simpler gene expression estimates based on the list of genes associated to each reaction. For
yeast (a), the upper and lower triangles are the 75% and 85% maximum growth conditions, respectively, and human
is done similarly with the K562 and MDA-MB-231 cell lines (b). As for expression estimates, the sum of expression
and enzyme complex estimate levels are generally the least correlated with other expression estimates. As expected,
the enzyme complex estimates are the most correlated with the FALCON fluxes, as they are used in the algorithm.
However, it is important to note that they are not very similar, exemplifying the affect the network constraints play
when determining flux. Interestingly, enzyme complex abundance is found to correlate very highly with the maximum
expression level for the complex; this can be attributed to many genes having relatively simple complexes that are
isozymes, where one major isozyme is typically highly expressed.
8 Assumptions for enzyme complex formation
In order to quantify enzyme complex formation (sometimes called enzyme complexation), the notion of an enzyme
complex should be formalized. A protein complex typically refers to two or more physically associated polypeptide
chains, which is sometimes called a quaternary structure. Since we are not exclusively dealing with multiprotein
complexes, we refer to an enzyme complex as being one or more polypeptide chains that act together to carry out
metabolic catalysis.
19
(a)
(b)
Figure 10: Correlation between proteomic datasets obtained from two different instruments (a); left, proteins that
were detected are shown as zeros, whereas they are filtered in the middle, and only metabolic genes are shown on the
right. In (b), these proteomic datasets (with zeros removed) are correlated with an mRNA (microarray) dataset.
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Assumption 1. A fundamental assumption that we need in order to guarantee an accurate estimate of (unitless)
enzyme complex abundance are the availability of accurate measurements of their component subunits. Unfortunately,
this is currently not possible, and we almost always must make do with mRNA measurements, which may even have
some degree of inaccuracy in measuring the mRNA abundance. What has been seen is that Spearman’s ρ = 0.6 for
correlation between RNA-Seq and protein intensity in datasets from HeLa cells [32]. We also found that there is
moderate correlation (Pearson’s r = 0.5) between proteomic and microarray data and fairly strong correlation between
proteomic data obtained from different instruments (Pearson’s r = 0.7; Figure 10). This implies that much can likely
still be gleaned from analyzing various types of expression data, but, an appropriate degree of caution must be used
in interpreting results. By incorporating more information, such as metabolic constraints, we hope to obviate some of
the error in estimating protein intensity from mRNA data.
Assumption 2. We also include the notion of isozymes–different proteins that catalyze the same reaction–in our
notion of enzyme complex. Isozymes may arise by having one or more differing protein isoforms, and even though
these isoforms may not be present in the same complex at the same moment, we consider them to be part of the enzyme
complex since one could be substituted for the other.
As an example for assumptions described so far, take the F1 subcomplex of ATP Synthase (Figure 11), which is
composed of seven protein subunits (distinguished by color, left). On the right-hand side we see different isoforms
depicted as different colors. Error in expression data aside, instead of considering the abundances with multiplicity
and dividing their expression values by their multiplicity, it may be easier to simply note that the axle peptide (shown
in red in the center of the complex) only has one copy in the complex, so its expression should be an overall good
estimation of the F1 subcomplex abundance. This reasoning will be useful later in considering why GPR rules may be
largely adequate for estimating the abundance of most enzyme complexes.
Assumption 3. The modeling of enzyme complex abundance can be tackled by using nested sets of subcom-
plexes; each enzyme complex consists of multiple subcomplexes, unless it is only a single protein or family of protein
isozymes. These subcomplexes are required for the enzyme complex to function (AND relationships), and can be
thought of as the division of the complex in to distinct units that each have some necessary function for the complex,
with the exception that we do not keep track of the multiplicity of subcomplexes within a complex since this informa-
tion is, in the current state of affairs, not always known. However, there may be alternative versions of each functional
set (given by OR relationships). Eventually, this nested embedding terminates with a single protein or set of peptide
isoforms (e.g. isozymes). In the case of ATP Synthase, one of its functional sets is represented by the F1 subcomplex.
The F1 subcomplex itself can be viewed as having two immediate subcomplexes: the single γ (axle) subunit and three
identical subcomplexes each made of an α and β subunit. Each αβ pair works together to bind ADP and catalyze the
reaction [36]. The αβ subcomplex itself then has two subcomplexes composed of just an α subunit on the one hand
and the β subunit on the other. It is obvious that one of these base-level functional subcomplexes (in this example,
either γ or αβ) will be in most limited supply, and that it will best represent the overall enzyme complex abundance
(discounting the issues of multiplicity for αβ, see Assumption 4).
The hierarchical structure just described, when written out in Boolean, will give a rule in CNF (conjunctive normal
form), or more specifically (owing to the lack of negations), clausal normal form, where a clause is a disjunction of
literals (genes). This is because all relations are ANDs (conjunctions), except possibly at the inner-most subcomplexes
that have alternative isoforms, which are expressed as ORs (disjunctions). Since GPR rules alone only specify the
requirements for enzyme complex formation, we will see that not all forms of Boolean rules are equally useful in
evaluating the enzyme complex abundance, but we have established the assumptions in Table 2 and an alternative and
logically equivalent rule [16] under which we can estimate enzyme complex copy number.
There is no guarantee that a GPR rule has been written down with this hierarchical structure in mind, though it is
likely the case much of the time as it is a natural way to model complexes. However, any GPR rule can be interpreted
in the context of this hierarchical view due to the existence of a logically equivalent CNF rule for any non-CNF rule,
and it is obvious that logical equivalence is all that is required to check for enzyme complex formation when exact
isoform stoichiometry is unknown. As an example, we consider another common formulation for GPR rules, and a
way to think about enzyme structure—disjunctive normal form (DNF). A DNF rule is a disjunctive list of conjunctions
of peptide isoforms, where each conjunction is some variation of the enzyme complex due to substituting in different
isoforms for some of the required subunits. A rule with a more complicated structure and compatible isoforms across
subcomplexes may be written more succinctly in CNF, whereas a rule with only very few alternatives derived from
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Figure 11: Illustration of the F1 part of the ATP Synthase complex (PDB ID 1E79; Gibbons et al. 33, Bernstein et al.
34, Gezelter et al. 35). This illustration demonstrates both how an enzyme complex may be constituted by multiple
subunits (left), and how some of those subunits may be products of the same gene and have differing stoichiometries
within the complex (right).
Table 2: A list of assumptions about how Gene-Protein-Reaction rules can describe enzyme complex stoichiometry.
Table 2. Assumptions in GPR-based Enzyme Complex Formation
1. Expression values are highly correlated with the copy numbers of their corresponding peptide iso-
forms.
2. Protein isoforms contributing to isozymes are considered part of the same enzyme complex.
3. Any enzyme complex can be described as a hierarchical subset of (possibly redundant) subcom-
plexes; redundant subcomplexes, as elaborated in (4), are not currently modeled.
4. Assume one copy of peptide per complex; exact isoform stoichiometry is not considered.
5. With the exception of complexes having identical rules (i.e. the same complex listed for different
reactions), each copy of a peptide is available for all complexes in the model.
6. There is only one active site per enzyme complex.
7. We assume that different pathways have similar flux sensitivities with respect to their enzyme abun-
dances.
8. If a particular subcomplex can be catalyzed by A and it can also be catalyzed by A and B (e.g.
B acts as a regulatory unit, as in holoenzymes), this just simplifies to A once expression values are
substituted in. Similarly, allosteric regulation is not modeled. Relatedly, there are no NOT operations
in GPR rules (just ANDs and ORs).
9. Enzyme complexes form without the assistance of protein chaperones and formation is not coupled
to other reactions.
10. Post-translational modifications do not affect complex formation.
11. Rate of formation and degradation of complexes doesn’t play a role, since we assume steady-state.
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isoform variants may be represented clearly with DNF. In rare cases, it is possible that a GPR rule is written in neither
DNF or CNF, perhaps because neither of these two alternatives above are strictly the case, and some other rule is more
succinct.
Assumptions 4, 5 and 6. One active site per enzyme complex implies a single complex can only catalyze one
reaction at a time. Multimeric complexes with one active site per identical subunit would be considered as one
enzyme complex per subunit in this model. Note that it is possible for an enzyme complex to catalyze different
reactions. In fact, some transporter complexes can transfer many different metabolites across a lipid bilayer—up to
294 distinct reactions in the reversible model for solute carrier family 7 (Gene ID 9057). Another example is the
ligation or hydrolysis of nucleotide, fatty acid, or peptide chains, where chains of different length may all be substrates
or products of the same enzyme complex. While we do not explicitly consider these in in the minimum disjunction
algorithm, these redundancies are taken into account subsequently in Algorithm 3.1.
In order to explore the effect that stoichiometry of protein complexes can have on metabolism, we compared time
series aggregates of fluxes and metabolite counts from a whole cell model of Mycoplasma genitalium [37] in two
different conditions (Figure 12). While there are outliers and deviations from perfect correlation, the results indicate
that, at least in a whole cell model of M. genitalium, our assumption for protein complex stoichiometry may be
acceptable. Nonetheless, we hope to address this assumption at a future date.
What is currently not considered in our process is that some peptide isoforms may find use in completely different
complexes, and in some cases, individual peptides may have multiple active sites; in the first case, we assume an
unrealistic case of superposition where the isoform can simultaneously function in more than one complex. The
primary reason we have not tackled this problem is because exact subunit stoichiometry of most enzyme complexes
is not accurately known, but an increasing abundance of data on BRENDA [38] gives some hope to this problem. A
recent E. coli metabolic model incorporating the metabolism of all known gene products [39] also includes putative
enzyme complex stoichiometry in GPR rules. For the second point, there are a few enzymes where a single polypeptide
may have multiple active sites (e.g. fatty acid synthase), and this is not currently taken into account in our model. One
way that we may take this into account has been illustrated online by one of the authors [40].
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Figure 12: The Whole Cell model was simulated for 9000 seconds with both default (WT) and simplified unitary
(Perturb) protein complex stoichiometry. Among 645 total metabolic fluxes, 298 had nonzero flux in both conditions.
We calculated the sum of each of these 298 fluxes across 9000 seconds. We omitted 10 fluxes whose overall sum was
of different sign between WT and Perturb, took the log10 value of the remaining 288 fluxes, and plotted these values,
in both WT and Perturb (a). Similarly, among 722 total metabolites, 182 had nonzero counts in both conditions. We
calculated the sum of each of the counts of these 182 metabolites across 9000 seconds, took the log10 of these values,
and plotted them in both WT and Perturb (b). In both cases, the red line indicates the line of best fit for the Pearson’s
correlation.
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Assumption 8. We do not make any special assumptions requiring symmetry of an isoform within a complex. For
instance, the example in assumption 8 shows how you might have one subcomponent composed of a single isoform,
and another subcomponent composed of that gene in addition to another isoform. In this case, it is simply reduced to
being the first gene only that is required, since clearly the second is strictly optional. That isn’t to say that the second
gene may not have some metabolic effect, such as (potentially) aiding in structural ability or altering the catalytic
rate, but it should have no bearing on the formation of a functional catalytic complex. Holoenzymes—enzymes with
metabolic cofactors or protein subunits that have a regulatory function for the complex—would likely be the only
situation where this type of rule might need to be considered in more detail. But in the absence of detailed kinetic
information, this consideration (much like allosteric regulation) is not useful.
No additional algorithmic considerations are needed, as this is a by-product of the conversion to CNF. For instance,
take the following example where the second conjunction has the redundant gene g3:
(g1 ∧ g2) ∨ (g1 ∧ g2 ∧ g3)
Distributing during the process of conversion to CNF results in:
g1 ∧ (g1 ∨ g2) ∧ (g1 ∨ g3) ∧ (g2 ∨ g1) ∧ g2 ∧ (g2 ∨ g3)
Because every disjunction with more than one literal is in conjunction with another disjunction with only one of
its literals, the disjunction with fewer literals will be the minimum of the two once evaluated. This applies to both of
the singleton disjunctions g1 and g2, so all other disjunctions will effectively be ignored (it is up to the implementer
whether the redundant sub-expressions are removed before evaluation):
g1 ∧
❳
❳
❳
❳❳
(g1 ∨ g2)∧❳❳❳❳❳(g1 ∨ g3)∧
❳
❳
❳
❳❳
(g2 ∨ g1)∧g2❳❳❳❳❳∧(g2 ∨ g3) = (g1 ∧ g2)
Assumption 7. Another important biochemical assumption is that reactions should operate in a regime where they
are sensitive to changes in the overall enzyme level in the pathways that they belong in [24, 25]. This is perhaps the
most important issue to be explored further for methods like this, since if it is not true, some other adjustment factor
would be needed to make the method realistic. For instance, if all reactions in a pathway are operating far below Vmax,
but it is not the case in another pathway, the current method does not have information on this, and will try to put more
flux through the first pathway than should be the case.
Assumptions 9, 10 and 11. Due to the quickness, stability, and energetic favorability of enzyme complex formation,
the absence of chaperones or coupled metabolic reactions required for complex formation may be reasonable assump-
tions, but further research is warranted [37]. Additionally, as in metabolism, we assume a steady state for complex
formation, so that rate laws regarding complex formation aren’t needed. However, further research may be warranted
to investigate the use of a penalty for complex levels based on mass action and protein-docking information. Requisite
to this would be addressing assumption 4. It would be surprising (but not impossible) if such a penalty were very large
due to the cost this would imply for many of the large and important enzyme complexes present in all organisms [41].
A more serious consideration may be that information on post-translational modification is not currently considered.
Post-translational modification is highly context-specific and the relevant data is not as cheap to get as expression data,
so it may be some time before it can be integrated into the modeling framework.
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Table 3: Running times (in seconds, ± standard deviation) for FALCON using various algorithms implemented in the
Gurobi package. For yeast models, 1,000 replicates were performed, and for the human model, 100 replicates were
performed.
Model Primal-Simplex Dual-Simplex Barrier
Yeast 5.21 (2,061 reactions) 7.841 ± 1.697 7.611 ± 1.267 10.859 ± 2.788
Yeast 7.0 (3,498 reactions) 51.863 ± 22.731 65.317 ± 12.771 242.137 ± 57.129
Human 2.03 (7,440 reactions) 159.077 ± 24.903 152.297± 39.783 366.166 ± 92.321
Table 4: Running time per FALCON iteration (in seconds, ± standard deviation) using various algorithms imple-
mented in the Gurobi package. For yeast models, 1,000 replicates were performed, and for the human model, 100
replicates were performed.
Model Primal-Simplex Dual-Simplex Barrier
Yeast 5.21 (2,061 reactions) 0.721 ± 0.023 0.652 ± 0.040 1.100 ± 0.112
Yeast 7.0 (3,498 reactions) 2.725 ± 0.298 2.469 ± 0.289 11.309 ± 1.589
Human 2.03 (7,440 reactions) 6.422 ± 0.484 5.233 ± 0.661 15.782 ± 3.209
9 Benchmarking of solvers
We have exclusively used the Gurobi solver [42] for this work, which is a highly competitive solver that employs
by default a parallel strategy to solving problems: a different algorithm is run simultaneously, and as soon as one
algorithm finished the others terminate. Of course, if there is a clear choice of algorithm for a particular problem
class, this should be used in production settings to avoid wasted CPU time and memory. In order to address this,
we benchmarked the three non-parallel solver methods in Gurobi (since parallel solvers simply use multiple methods
simultaneously). The exception to this rule is the Barrier method, which can use multiple threads, but in practice for
our models appears to use no more than about 6 full CPU cores simultaneously for our models. Our results for Yeast 5
and Yeast 7 with minimal directionality constraints [8, 18, 22] and Human Recon 2 [19] are shown in Table 3).
We found that in Yeast 7 with the primal-simplex solver, there is a chance the solver will fail to find a feasible solu-
tion. We verified that this is a numeric issue in Gurobi and can be fixed by setting the Gurobi parameter MarkowitzTol
to a larger value (which decreases time-efficiency but limits the numerical error in the simplex algorithm). In practice,
failure for the algorithm to converge at an advanced iteration is rare and is not always a major problem (since the pre-
vious flux estimate by the advanced iteration should already be quite good), but it is certainly undesirable; a warning
message will be printed by falcon if this occurs, at which point parameter settings can be investigated. In the future,
we plan to improve falcon so that parameters will be adjusted as needed during progression of the algorithm after
finding a good test suite of models and data. For now, we use the dual-simplex solver, for which we have always had
good results.
Because the number of iterations depends non-trivially on the model and the expression data, it may be more
helpful to look at the average time per iteration in the above examples (Table 4).
Given the above rare trouble with primal simplex solver the universal best performance enjoyed by the dual-
simplex method (Tables 3 and 4), we would advise the dual-simplex algorithms, all else being equal. The dual-simplex
method is also recommended for memory-efficiency by Gurobi documentation, but we did not observe any differences
in memory for different solver methods.
All timing analyses were performed on a system with four 8-core AMD Opteron™ 6136 processors operating at
2.4 GHz. Figure 6, Table 1, and Tables 3 and 4 used a single unperturbed expression file per species (S. cerevisiae
and H. sapiens; see timingAnalysis.m for details). Values were averaged across 32 replicates. Note that the iMAT
method is formulated as a mixed integer program [14], and was able to use additional parallelization of the solver
[42] whereas other methods only used a single core (our system had 32 cores and iMAT with Gurobi would use all
of them). Tables 3 and 4 used multivariate log-normal noise multiplied by the original expression vector to introduce
more variance in the calculations; the human models were tested with 100 replicates and the yeast models with 500
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replicates.
10 Generation of figures and tables
All non-trivial figures can be generated using MATLAB scripts found in the analysis/figures subdirectory of the
FALCON installation. In particular, figures should be generated through the master script makeMethodFigures.m
by calling makeMethodFigures(figName) where figName has a name corresponding to the desired figure. In
some cases, some MATLAB .mat files will need to be generated by other scripts first; see the plotting scripts or the
subsections below for details. An example is to make the scatter plots showing the difference between running falcon
with enzyme abundances determined by direct evaluation or the minimum disjunction algorithm; all three scatter plots
are generated with the command makeMethodFigures('fluxCmpScatter'). Note that, as written, this requires a
graphical MATLAB session.
Several figures can be generated that are related to comparing human proteomic and transcriptomic data by exe-
cuting the script proteomic file make.py in the analysis/nci60 subdirectory; this includes Figure 10.
Comparison of the effects of the employed enzyme complexation methods were evaluated using
compareEnzymeExpression.m and compareFluxByRGroup.m. Comparison of reaction groups was performed in
compareFluxByRGroup.m.
10.1 Timing analyses
All timing analyses were performed on a system with four 8-core AMD Opteron™ 6136 processors operating at 2.4
GHz. Figure 6 and Table 1 used unperturbed expression data; see yeastResults.m for details). Values for the
FALCON method were averaged across 32 replicates, while values for the Lee et al. 8 method were averaged across 8
replicates. Human timing analyses were performed using methodTimer.mwith 8 replicates.
10.2 Data sources
Enzyme complexation comparisons were performed on proteomics data from Gholami et al. 21 (Human; 786-O cell
line) and Picotti et al. 20 (yeast; BY strain), and on RNA-Seq data from Lee et al. 8 (yeast; 75% max µ condition).
Human proteomic and trascriptomic data used for comparison in Figure 10 were taken from Gholami et al. 21.
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